Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Choosing the best Dividend Aristocrats Etf for retirees involves yield, cost, and risk assessment. This intro guides the evaluation process.
22,751 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
A newly launched active ETF has delivered stronger net returns than the S&P 500 after costs over the latest 12-month ...
Cash flow from senior housing and warehouse REITs is holding steady even as refinancing costs rise. The payout outloo...
With summer on the horizon, investors wonder if XLE should ride along in their portfolios. This guide weighs the case...
SpaceX's IPO spark has investors buzzing, but Warren Buffett would never chase hype without a moat and predictable ca...
Silver often moves with industrial demand and macro trends. After a 28% correction in SLV, investors face a key quest...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
Global X's RYLD, a Russell 2000 covered-call ETF, underperforms uncapped peers this year as small-cap volatility ease...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...
Is UPS stock a long-term winner? This guide breaks down the turnaround story, real numbers, and a clear plan for eval...
Investors woke up to a move in Comcast shares after strategic news and improving fundamentals. This article breaks do...
As energy markets shift, investors must decide between EQT's pure-play gas model and Occidental's global oil mix. Thi...